ROSUVIBE GOLD Capsule is a targeted and effective solution for individuals dealing with atherosclerotic cardiovascular diseases (CVD), acute coronary syndrome (ACS), and stroke. This capsule is designed to significantly improve the lipid profile, leading to a reduction in cardiac events. With the inclusion of Rosuvastatin, ROSUVIBE GOLD Capsule demonstrates a remarkable 44% reduction in the risk of myocardial infarction (MI), stroke, and death. Notably, it goes beyond traditional antiplatelet options, as it reduces the risk of stroke and MI events by 22.7% more than aspirin.
As a preferred antiplatelet agent for preventing vascular events, ROSUVIBE GOLD Capsule stands out for its efficacy in mitigating the risks associated with atherosclerotic CVD, ACS, and stroke. This makes it a valuable choice for individuals seeking comprehensive and reliable cardiovascular support.
In Atherosclerotic CVD, ACS and Stroke
Tell us a little more about yourself so we can deal with your enquiry.
Reviews